Article Detail
Source | Electronic ID | Title | Authors | Publication Year | Source Title▼ | Volume | Issue | DOI | Affiliations | Authors with Affiliations | Abstract | Author Keywords | Index Keywords | Funding Details | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scopus | 2-s2.0-84884124849 | The impact of pharmaceutical care intervention on the quality of life of nigerian patients receiv... | Adibe M.O., Ukwe C.V., Aguwa C.N. | 2013 | Value in Health Regional Issues | 2 | 2 | 10.1016/j.vhri.2013.06.007 | Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsukka, Enugu, Ni... | Adibe, M.O., Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsuk... | Objectives: To evaluate the impact of pharmaceutical care (PC) intervention on health-related qua... | HRQOL; Patients with diabetes; Pharmaceutical care intervention; Quality of life; Usual care | adult; article; cerebrovascular accident; chi square test; comorbidity; controlled study; disease... | None | |
Scopus | 2-s2.0-84884132277 | Systematic review of economic evaluation literature in Ghana: Is health technology assessment the... | Odame E.A. | 2013 | Value in Health Regional Issues | 2 | 2 | 10.1016/j.vhri.2013.07.006 | Ghana College of Physicians and Surgeons, Accra, Ghana | Odame, E.A., Ghana College of Physicians and Surgeons, Accra, Ghana | Objectives: In many countries, such as Ghana, there is an increasing impetus to use economic eval... | Economic evaluation; Ghana; Medical devices; Pharmaceuticals | article; cost; decision making; economic evaluation; Ghana; health care policy; health impact ass... | None | |
Scopus | 2-s2.0-84915784151 | Economic evaluation of a cluster randomized trial of interventions to improve health workers' pra... | Mangham-Jefferies L., Wiseman V., Achonduh O.A., Drake T.L., Cundill B., Onwujekwe O., Mbacham W. | 2014 | Value in Health | 17 | 8 | 10.1016/j.jval.2014.07.010 | Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-1... | Mangham-Jefferies, L., Department of Global Health and Development, London School of Hygiene and ... | Background Malaria rapid diagnostic tests (RDTs) are a valid alternative to malaria testing with ... | Cameroon cluster-randomized trial; cost-effectiveness analysis; health worker training; malaria p... | antimalarial agent; artemisinin; adolescent; adult; Article; Cameroon; child; controlled study; c... | ACT, Arts and Culture Trust | |
WoS | WOS:000345469000029 | The impact of introducing new vaccines on the health system: Case studies from six low- and middl... | Burchett, Helen E. D.,Chavez, Enrique,Edengue, Jean-Marie,Gelmon, Lawrence,Griffiths, Ulla K.,Kit... | 2014 | VACCINE | 33 | 49 | 10.1016/j.vaccine.2014.09.032 | Addis Ababa University, University of London, University of Manitoba, University of Nairobi, Univ... | "Burchett, Helen E. D.: University of London","Griffiths, Ulla K.: University of London","Lagarde... | Objective: We aimed to explore the impacts of new vaccine introductions on immunization programme... | "HEALTH SYSTEMS","immunisation programmes",INTRODUCTIONS,"new vaccines",AFRICA,"ELIMINATION ACTIV... | None | None | |
None | None | Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania | Goodson J.L., Wiesen E., Perry R.T., Mach O., Kitambi M., Kibona M., Luman E.T., Cairns K.L. | 2009 | Vaccine | 27 | 42 | 10.1016/j.vaccine.2009.07.057 | Centers for Disease Control and Prevention, United States; World Health Organization, Africa Regi... | Goodson, J.L., Centers for Disease Control and Prevention, United States; Wiesen, E., World Healt... | We assessed the impact of a measles outbreak response vaccination campaign (ORV) in Dar es Salaam... | Immunization; Measles; Outbreak; Vaccination | measles vaccine; adolescent; adult; age distribution; article; child; controlled study; epidemic;... | None | |
Scopus | 2-s2.0-80051470804 | The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: A mo... | Nagelkerke N.J.D., Hontelez J.A.C., de Vlas S.J. | 2011 | Vaccine | 29 | 36 | 10.1016/j.vaccine.2011.06.048 | Department of Community Medicine, United Arab Emirates University, P.O. Box 17666, Al Ain, United... | Nagelkerke, N.J.D., Department of Community Medicine, United Arab Emirates University, P.O. Box 1... | Background: The RV144 trial on the ALVAC/AIDSVAX candidate HIV vaccine, carried out in Thailand, ... | HIV; Modeling; Population impact; Targeting | alvac; Human immunodeficiency virus vaccine; unclassified drug; article; compartment model; cost ... | None | |
Scopus | 2-s2.0-84869088741 | Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratub... | Santema W.J., Poot J., Segers R.P.A.M., Van den Hoff D.J.P., Rutten V.P.M.G., Koets A.P. | 2012 | Vaccine | 30 | 49 | 10.1016/j.vaccine.2012.09.065 | Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht Univers... | Santema, W.J., Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, ... | Efficient control of bovine paratuberculosis is hampered by lack of a vaccine. The purpose of thi... | Cattle; Efficacy; Hsp70; Paratuberculosis; Subunit vaccine; Transmission | bacterial vaccine; recombinant mycobacterium avium subspecies paratuberculosis heat shock protein... | None | |
Scopus | 2-s2.0-80051471460 | The potential impact of RV144-like vaccines in rural South Africa: A study using the STDSIM micro... | Hontelez J.A.C., Nagelkerke N., Bärnighausen T., Bakker R., Tanser F., Newell M.-L., Lurie M.N., ... | 2011 | Vaccine | 29 | 36 | 10.1016/j.vaccine.2011.06.059 | Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherla... | Hontelez, J.A.C., Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, R... | Background: The only successful HIV vaccine trial to date is the RV144 trial of the ALVAC/AIDSVAX... | Cost-effectiveness; HIV vaccine; Mathematical model; Microsimulation model; South Africa | Human immunodeficiency virus vaccine; RV144; RV144 like vaccine; unclassified drug; adolescent; a... | None | |
Scopus | 2-s2.0-84858280812 | Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduct... | Abbott C., Tiede B., Armah G., Mahmoud A. | 2012 | Vaccine | 30 | 15 | 10.1016/j.vaccine.2012.01.076 | Departments of Ecology and Evolutionary Biology Molecular Biology, Woodrow Wilson School of Publi... | Abbott, C., Departments of Ecology and Evolutionary Biology Molecular Biology, Woodrow Wilson Sch... | Background: Globally, rotavirus gastroenteritis is the most common identifiable cause of severe d... | Cost-effectiveness; Ghana; Rotavirus vaccine | Rotavirus vaccine; article; childhood disease; cost effectiveness analysis; drug cost; female; Gh... | None | |
Scopus | 2-s2.0-34247121753 | Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine | Dennehy M., Bourn W., Steele D., Williamson A.-L. | 2007 | Vaccine | 25 | 18 | 10.1016/j.vaccine.2007.01.087 | Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of Health Scien... | Dennehy, M., Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of... | Recombinant BCG expressing rotavirus VP6 was explored as an anti-rotavirus vaccine in a mouse mod... | BCG; Rotavirus; VP6 | BCG vaccine; cytoplasm protein; heat shock protein 60; lipoprotein; protein VP6; recombinant vacc... | None | |
Scopus | 2-s2.0-84946574725 | Hepatitis B virus infection in northern Uganda: Impact of pentavalent hepatitis B vaccination | Teshale E.H., Kamili S., Drobeniuc J., Denniston M., Bakamutamaho B., Downing R. | 2015 | Vaccine | 33 | 46 | 10.1016/j.vaccine.2015.09.058 | Division of Viral Hepatitis, CDC, Atlanta, United States; Uganda Virus Research Institute, Entebb... | Teshale, E.H., Division of Viral Hepatitis, CDC, Atlanta, United States; Kamili, S., Division of ... | Chronic hepatitis B virus infection (CHBI) is effectively prevented by vaccination starting at bi... | Birth-dose; Hepatitis B virus; Mother-to-infant transmission; Pentavalent vaccine; Prevalence | hepatitis B vaccine; adult; age distribution; Article; child; child health care; hepatitis B; hum... | None | |
Scopus | 2-s2.0-84880723820 | Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness ... | Izurieta H.S., Zuber P., Bonhoeffer J., Chen R.T., Sankohg O., Laserson K.F., Sturkenboom M., Lou... | 2013 | Vaccine | 31 | 35 | 10.1016/j.vaccine.2013.05.027 | Food and Drug Administration (FDA), MD, United States; World Health Organization, Geneva, Switzer... | Izurieta, H.S., Food and Drug Administration (FDA), MD, United States; Zuber, P., World Health Or... | With the advent of new vaccines targeted to highly endemic diseases in low- and middle-income cou... | Adverse events; Benefit-risk; Effectiveness; Safety; Vaccine | Rotavirus vaccine; vaccine; article; Brazil; clinical evaluation; communicable disease; demograph... | Wellcome Trust | |
Scopus | 2-s2.0-84904400786 | Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone... | Wallace A.S., Masresha B.G., Grant G., Goodson J.L., Birhane H., Abraham M., Endailalu T.B., Leta... | 2014 | Vaccine | 32 | 35 | 10.1016/j.vaccine.2014.06.035 | Global Immunization Division, Centers for Disease Control and Prevention, 1600 Clifton Road, MS-E... | Wallace, A.S., Global Immunization Division, Centers for Disease Control and Prevention, 1600 Cli... | Objective: To estimate the economic impact of a measles outbreak and response activities that occ... | Economic; Measles; Outbreak | cotrimoxazole; measles vaccine; oral rehydration solution; retinol; tetracycline; adolescent; art... | None | |
Scopus | 2-s2.0-84916221953 | Monitoring coverage of fully immunized children | Tsega A., Daniel F., Steinglass R. | 2014 | Vaccine | 32 | 52 | 10.1016/j.vaccine.2014.10.057 | Maternal and Child Health Integrated Program (MCHIP), 1776 Massachusetts Ave, Suite 300, NW, Wash... | Tsega, A., Maternal and Child Health Integrated Program (MCHIP), 1776 Massachusetts Ave, Suite 30... | Immunization programs monitor 3rd dose of DPT-containing vaccine coverage as a principal indicato... | Fully immunized child; Immunization; National/global immunization/vaccination indicator; Vaccination | diphtheria pertussis tetanus vaccine; Article; child; East African; human; immunization; monitori... | None | |
Scopus | 2-s2.0-84903461899 | The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing ... | Idoko O.T., Okolo S.N., Plikaytis B., Akinsola A., Viviani S., Borrow R., Carlone G., Findlow H.,... | 2014 | Vaccine | 32 | 33 | 10.1016/j.vaccine.2014.04.052 | Medical Research Council Unit, P.O. Box 273, Gambia; Jos University Teaching Hospital, P.M.B. 208... | Idoko, O.T., Medical Research Council Unit, P.O. Box 273, Gambia; Okolo, S.N., Jos University Tea... | Major epidemics of serogroup A meningococcal meningitis continue to affect the African meningitis... | Antibody; Conjugate vaccine; Immune response; Meningococcal A; Pre-existing | immunoglobulin G; Meningococcus vaccine; polysaccharide vaccine; bacterium antibody; immunoglobul... | None | |
Scopus | 2-s2.0-34548550433 | Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda | Muganga N., Uwimana J., Fidele N., Gahimbare L., Gessner B.D., Mueller J.E., Mhlanga B.R., Katsan... | 2007 | Vaccine | 25 | None | 10.1016/j.vaccine.2007.06.032 | Ministry of Health, Expanded Programme on Immunization, Kigali, Rwanda; Centre Hospitalier Univer... | Muganga, N., Centre Hospitalier Universitaire de Kigali, Rwanda; Uwimana, J., Centre Hospitalier ... | Rwanda introduced Haemophilus influenzae type b (Hib) conjugate vaccine in January 2002 and simul... | Epidemiology; Haemophilus influenzae; Meningitis; Rwanda; Vaccine; Vaccine effectiveness; Vaccine... | antiretrovirus agent; diphtheria pertussis tetanus vaccine; Haemophilus influenzae type b vaccine... | None | |
Scopus | 2-s2.0-33747588525 | The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in... | Daza P., Banda R., Misoya K., Katsulukuta A., Gessner B.D., Katsande R., Mhlanga B.R., Mueller J.... | 2006 | Vaccine | 24 | None | 10.1016/j.vaccine.2006.05.076 | Mzuzu Central Hospital, Mzuzu, Malawi; World Health Organization, Lilongwe, Malawi; Queen Elizabe... | Daza, P., Mzuzu Central Hospital, Mzuzu, Malawi; Banda, R., World Health Organization, Lilongwe, ... | Malawi has extreme poverty and a high-human immunodeficiency virus (HIV) prevalence. Following Ha... | Haemophilus influenzae; Malawi; Vaccine effectiveness | amoxicillin; chloramphenicol; diphtheria pertussis tetanus vaccine; Haemophilus influenzae type b... | None | |
Scopus | 2-s2.0-84930606468 | Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains agai... | Gari G., Abie G., Gizaw D., Wubete A., Kidane M., Asgedom H., Bayissa B., Ayelet G., Oura C.A.L.,... | 2015 | Vaccine | 33 | 28 | 10.1016/j.vaccine.2015.01.035 | National Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, Ethiopia; National V... | Gari, G., National Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, Ethiopia; ... | The safety, immunogenicity and efficacy of three commercially available vaccines against lumpy sk... | Cattle; Gorgangoat pox strain; Kenyan sheep and goat pox strain; Lumpy skin disease; Neethling st... | gorgan goat pox vaccine; live vaccine; lumpy skin disease virus vaccine; neethling and kenyan she... | None | |
Scopus | 2-s2.0-84925969577 | Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: The case of K... | Carias C., Walters M.S., Wefula E., Date K.A., Swerdlow D.L., Vijayaraghavan M., Mintz E. | 2015 | Vaccine | 33 | 17 | 10.1016/j.vaccine.2015.02.027 | Office of Science and Integrated Programs, Centers for Disease Control and Prevention, Atlanta, G... | Carias, C., Office of Science and Integrated Programs, Centers for Disease Control and Prevention... | Background: Vaccination has been increasingly promoted to help control epidemic and endemic typho... | Cost-effectiveness; Typhoid; Typhoid vaccination; Uganda | typhoid vaccine; typhoid paratyphoid vaccine; Article; disability adjusted life year; economic ev... | None | |
Scopus | 2-s2.0-77953123428 | Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep | Dungu B., Louw I., Lubisi A., Hunter P., von Teichman B.F., Bouloy M. | 2010 | Vaccine | 28 | 29 | 10.1016/j.vaccine.2010.04.085 | Onderstepoort Biological Products Ltd., Private Bag X07, Onderstepoort, 0110, South Africa; ARC-O... | Dungu, B., Onderstepoort Biological Products Ltd., Private Bag X07, Onderstepoort, 0110, South Af... | The efficacy and safety of the naturally attenuated Rift Valley Fever (RVF) Clone 13 vaccine were... | Rift Valley Fever; Sheep; Vaccine | Rift Valley fever clone 13 vaccine; unclassified drug; virus vaccine; animal experiment; animal m... | None |